Medicine
Sodium nitrite 300 mg/10 mL injection
Sodium nitrite 300 mg/10 mL injection is a generic prescription medicine for intravenous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze. (Note: Sodium Thiosulfate must be obtained separately.) Protect…
Key facts
- Active ingredient (INN)
- Sodium nitrite
- Brand
- Sold under the generic name
- Strength
- 300 mg/10 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 10 mL
- Manufacturer
- Hope Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Do not freeze. (Note: Sodium Thiosulfate must be obtained separately.) Protect from direct light. Store at controlled room temperature between 20°C and 25°C (68°F to 77°F), excursions permitted from 15 to 30°C (59 to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- V03AB08 Sodium nitrite
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 14 February 2012
- Identifiers
- RxCUI 253010DailyMed set ID 52f01c6e-172a-47a9-98a6-9eab7651a032NDC 60267-311Application NDA203922
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 mL in 1 vial, single-use | 60267-311-10 | Hope Pharmaceuticals | 14 February 2012 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 14 February 2012 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Sodium nitrite is a prescription medicine indicated for sequential use with sodium thiosulfate for the treatment of acute cyanide poisoning that is judged to be serious or life-threatening. It is available as injection for intravenous use. MedsAcross supplies Sodium nitrite for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Sodium nitriteFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Sodium Nitrite prescribing information (Hope Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Sodium nitrite 300 mg/10 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.